Community-Acquired Pneumonia

>

Latest News

Pneumococcal Vaccine Elicits Immune Responses to 21 Serotypes in Children With 1 or More Health Conditions
Pneumococcal Vaccine Elicits Immune Responses to 21 Serotypes in Children With 1 or More Health Conditions

September 12th 2025

Merck reported the results for its phase 3 trial for its vaccine, Capvaxive, which was found to be noninferior to the pneumococcal 23-valent polysaccharide vaccine (PPSV23) for each of the 12 serotypes shared between the vaccines.

PCR Testing of Pneumonia in ICU Improves Treatment Costs but Not Cure Rate
PCR Testing of Pneumonia in ICU Improves Treatment Costs but Not Cure Rate

September 4th 2025

Barriers That Reduce Pneumococcal Vaccine Uptake Among Seniors
Barriers That Reduce Pneumococcal Vaccine Uptake Among Seniors

June 8th 2025

Streptococcus Pneumoniae Bacteremia Secondary to Community-Acquired Pneumonia: Another Case of Shorter Is Better?
Streptococcus Pneumoniae Bacteremia Secondary to Community-Acquired Pneumonia: Another Case of Shorter Is Better?

January 13th 2025

Men Experience More Pronounced Health Decline After Lower Respiratory Tract Infections
Men Experience More Pronounced Health Decline After Lower Respiratory Tract Infections

January 6th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.